TABLE 1.
Model Population Parameter | Commercial Population | Medicare Advantage Population | ||
Frequency, % | Patients, n | Frequency, % | Patients, n | |
Hypothetical plan membership | 1,000,000 | 1,000,000 | ||
Prevalence of chronic HF | 1.0a | 10,000 | 16.0b | 160,000 |
Chronic HF patients with systolic chronic HF | 52.9c | 5,290 | 52.9c | 84,640 |
With normal sinus rhythm | 66.8d | 3,534 | 66.8d | 56,540 |
With normal sinus rhythm and NYHA Class II to IV | 88.3d | 3,120 | 88.3d | 49,924 |
With normal sinus rhythm and NYHA Class II to IV with heart rate of ≥ 70 bpm | 61.3e | 1,913 | 61.3e | 30,604 |
Incidence of chronic HF | 0.1 | 1,000 | 3.1 | 31,000 |
Chronic HF patients with systolic chronic HF | 52.9c | 529 | 52.9c | 16,399 |
With normal sinus rhythm | 66.8d | 353 | 66.8d | 10,955 |
With normal sinus rhythm and NYHA Class II to IV | 88.3d | 312 | 88.3d | 9,673 |
With normal sinus rhythm and NYHA Class II to IV with heart rate of ≥ 70 bpm | 61.3e | 191 | 61.3e | 5,929 |
Total patients eligible for treatment (prevalent + incident populations) | 2,104 | 36,533 |
aChamberlain AM, Redfield MM, Alonso A, Weston SA, Roger VL. Atrial fibrillation and mortality in heart failure: a community study. 12
bCenters for Medicare & Medicaid Services. Chronic conditions among Medicare beneficiaries. Chartbook: 2012 edition. 13
cOwan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. 14
dFonarow GC, Albert NM, Curtis AB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). 15
eStudy of Anemia in a Heart Failure Population (STAMINA) registry (N = 1,090) from June 24, 2002, to July 11, 2003. bpm = beats per minute; HF = heart failure; NYHA = New York Heart Association.